The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Amarin’s (NASDAQ:AMRN) sell-off following the largely anticipated FDA approval of Vascepa has given investors a chance to buy the stock at an attractive valuation. However, … Continue Reading
Read now- With the announcement that Elan’s (NYSE:ELN) bapineuzumab candidate for Alzheimer’s disease failed again in a Phase III clinical trial, partners Pfizer (NYSE:PFE) and Johnson & … Continue Reading
Read now- A balloon-expandable stent system developed by Abbot Laboratories (NYSE:ABT) received FDA approval this morning for the treatment of iliac artery disease. A form of peripheral … Continue Reading
Read nowLong Ideas - Coronado Biosciences (NASDAQ:CNDO) announced that an investigator-sponsored Phase II clinical trial has begun evaluating the company’s novel immunotherapy in patients with ulcerative colitis (UC). CNDO-201, … Continue Reading
Read nowLong Ideas - The Celsion Corporation (NASDAQ:CLSN) in collaboration with Royal Phillips Electronics (NYSE:PHG) announced this morning that the FDA has approved a Phase II clinical trial of … Continue Reading
Read now- Shares of ViroPharma (NASDAQ:VPHM) are trading higher today after the company announced early this afternoon that the FDA approved its hereditary angioedema treatment Cinryze for … Continue Reading
Read now- Shares of Exelixis (NASDAQ:EXEL) are down 10% already in pre-market trading after the company announced a 20 million share public offering and $225 million principal … Continue Reading
Read now
